Related Experiment Video
Updated: Aug 18, 2025

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
GRP78 Activity Moderation as a Therapeutic Treatment against Obesity
Dongjin Pan1, Yunzhu Yang1, Aihua Nong1
1Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
Abstract:
Glucose-regulated protein 78 (GRP78), a molecular chaperone, is overexpressed in patients suffering from obesity, fatty liver, hyperlipidemia and diabetes. GRP78, therefore, can be not only a biomarker to predict the progression and prognosis of obesity and metabolic diseases but also a potential therapeutic target for anti-obesity treatment. In this paper, GRP78 inhibitors targeting its ATPase domain have been reviewed. Small molecules and proteins that directly bind GRP78 have been described. Putative mechanisms of GRP78 in regulating lipid metabolism were also summarized so as to investigate the role of GRP78 in obesity and other related diseases and provide a theoretical basis for the development and design of anti-obesity drugs targeting GRP78.
Related Concept Videos
Binge Eating Disorders
Obesity
Regulation of Food Intake
GPCRs Regulate Adenylyl Cylase Activity
Atherosclerosis III: Management
Bulimia Nervosa

